Title Image

Webinar: 2D vs. 3D – Assessment of hepatotoxicity in an advanced in vitro liver model

Webinar: 2D vs. 3D – Assessment of hepatotoxicity in an advanced in vitro liver model

February 4, 2025 | online | 11 am – 12 am (CET)

 

Webinar with CliniSciences

Topic: “2D vs. 3D – Assessment of hepatotoxicity in an advanced in vitro liver model”

Please register here.

About the Webinar:

 

In the first part, our CEO Dr. Martin Raasch will present insights into the development of an advanced liver organ model, focusing on:

 

/ Suitable cell types and culture conditions for transient expansion of primary human upcyte® LSECs.

/ Data on acetaminophen toxicity detection at millimolar concentrations using expandable upcyte® LSECs and upcyte® hepatocytes.

/ A comparison of test results from static 2D cultures and microphysiological 3D models.

 

In the second part, Dr. Quentin Lemasson from CliniSciences will highlight:

 

/ The characteristics and advantages of using upcyte® LSECs and hepatocytes.

/ An overview of the IxCyte and upcyte® projects, showcasing their benefits for scalability and reproducibility in laboratory research.

/ Practical applications and how these innovative tools are transforming liver toxicity studies.